-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On IDEXX Laboratories with Overweight Rating, Announces Price Target of $850

Benzinga·12/09/2025 14:54:50
Listen to the news
Barclays analyst Glen Santangelo initiates coverage on IDEXX Laboratories (NASDAQ:IDXX) with a Overweight rating and announces Price Target of $850.